Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates

Research To Practice | Oncology Videos · Apr 23, 2025 · 44m

Featuring an interview with Dr William K Oh, including the following topics:

Use of secondary hormonal agents for patients with metastatic hormone-sensitive prostate cancer (0:00)

Data supporting the clinical activity of PARP inhibitors for metastatic castration-resistant prostate cancer (mCRPC) (11:10)

Radiopharmaceuticals for the treatment of mCRPC (16:53)

Available data on cabozantinib for mCRPC (24:38)

Cabozantinib combinations for advanced renal cell carcinoma (RCC) (26:17)

Subcutaneous nivolumab versus intravenous nivolumab for advanced RCC (30:00)

Addition of nivolumab to tivozanib…